Unibest

Pharmaceutical intermediates

Delgocitinib Intermediates

1 pharmaceutical intermediate for Delgocitinib. Indication: Eczema; Dermatitis; Atopic dermatitis.

Submit a ProjectAll intermediates

About Delgocitinib

Originator
Leo Pharma As
Indication
Eczema; Dermatitis; Atopic dermatitis
Approved Date
07/23/2025
DS/DP
07/23/2030

Available intermediates

1 intermediate currently listed for Delgocitinib. Request specifications, documentation or a quotation for any item below.

Delgocitinib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
1,6-Diazaspiro[3.4]octane, 3-methyl-1-(phenylmethyl)-, ethanedioate (2:1), (3S,4R)-2230683-29-9//

Other programs under D

Dabigatran EtexilateDabigatran etexilate mesylateDabrafenib MesylateDacomitinibDanicopanDapagliflozinDaridorexant HydrochlorideDarolutamide

Building toward Delgocitinib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →